Aadi Bioscience Inc (NAS:AADI)
$ 1.41 0.01 (0.71%) Market Cap: 34.62 Mil Enterprise Value: -52.73 Mil PE Ratio: 0 PB Ratio: 0.38 GF Score: 30/100

Aerpio Pharmaceuticals Inc Annual Shareholders Meeting Transcript

Jun 24, 2020 / 02:30PM GMT
Operator

Thank you. It is now my pleasure to turn today's meeting over to Muneer Satter, Chairman of Aerpio. The floor is yours.

Muneer Satter

Okay. Thank you, Gigi. Good morning, everyone. My name is Muneer Satter, Chairman of the Board of Directors of Aerpio Pharmaceuticals. It's a pleasure to welcome every -- to welcome all of our stockholders and visitors to the 2020 Annual Meeting of Aerpio Pharmaceuticals. This meeting is being held in accordance with the company's bylaws and Delaware law and is being held virtually. We have stockholders attending via the web portal we've provided. The meeting is now called to order.

I've asked James Xu of Goodwin Procter, our outside legal counsel, to record the minutes. Before proceeding to the formal business, I would like to introduce the directors and officers of the company who are with us today. Our outside directors are Caley Castelein, Cheryl Cohen, Anupam Dalal, Pravin Dugel, Chau Khuong and Steven Prelack.

Our officers are Joseph Gardner, President and Principal Executive Officer; Regina Marek, Vice

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot